Board of Directors
William D. Anderson
Chair, Board of Directors
William Anderson, 59, of Toronto, Canada, has served on the Board since February 2007, and became Chairman in February 2010. Mr. Anderson is a Chartered Accountant and a Corporate Director, having retired in 2005 after serving 14 years with BCE Inc. From 2001 to 2004, Mr. Anderson was President of BCE Ventures, and from 1997 to 2000, was Chief Financial Officer of BCE Inc. Mr. Anderson is also a director of TransAlta Corporation and Gildan Activewear Inc.
Paul S. Anderson
Member of the Corporate Governance & Nominating Committee
Member of the Environment, Health and Safety Committee
Paul Anderson, PhD, 70, of Lansdale, U.S., has served on the Board of the Company since 2003. Dr. Anderson is a Corporate Director having retired in 2002 after a 40-year career in the pharmaceutical industry. From 2001 to 2003, Dr. Anderson was Vice-President, Drug Discovery at Bristol-Myers Squibb. Dr. Anderson is also a Director of Albany Molecular Research, a member of the Chemical Heritage Foundation, and is on the Board of Trustees of the Gordon Research Conferences.
William G. Dempsey
Member of the Audit Committee
Member of the Environment, Health and Safety Committee
Bill Dempsey, 57, of Green Oaks, US, was appointed to the Board in 2008. Mr. Dempsey was an Executive with Abbott Laboratories for 25 years, prior to his retirement in 2007. His assignments included Executive Vice-President of the Pharmaceutical Products Group and Senior Vice-President of International Operations. Mr. Dempsey is a former Director of TAP Pharmaceutical Products Inc., and is currently a Director of TyRx, Inc., Landauer Inc. and the MPD Foundation.
William A. Etherington
Chair of the Human Resources & Compensation Committee
Member of the Corporate Governance & Nominating Committee
Bill Etherington, 67, of Toronto, Canada, has served on the Board of the Company since 2001. Mr. Etherington is Chairman, Canadian Imperial Bank of Commerce. Prior to 2001, Mr. Etherington was Senior Vice-President & Group Executive, Sales & Distribution, IBM Corporation and Chairman, President and Chief Executive Officer, IBM World Trade Corporation. Mr. Etherington is also a Director of Celestica Inc., Onex Corporation, SS&C Technologies, Inc., and St. Michael's Hospital. He is also a member of the President’s Council, University of Western Ontario.
Robert W. Luba
Chair, Audit Committee
Member of the Human Resources & Compensation Committee
Bob Luba, 66, of Toronto, Canada, was appointed to the Board in 1996, and was named Chairman of the Audit Committee in February 2010. Mr. Luba is President, Luba Financial Inc. Prior to 1994, he was President and Chief Executive Officer of Royal Bank Investment Management Inc., President of Crown Life Insurance Company and Senior Vice-President of John Labatt Limited. Mr. Luba is also a Director of AIM Trimark Investments and Softchoice Corporation.
James S.A. MacDonald
Chair, Special Committee
Member of the Audit Committee
James MacDonald, 63, of Toronto, Canada, was appointed to the Company's Board of Directors in July 2005, and became Chairman in November 2008. Mr. MacDonald is Chairman and Managing Partner of Enterprise Capital Management Inc. Prior to 1997, Mr. MacDonald was Deputy Chairman of Scotia McLeod Inc., having joined a predecessor to that company in 1969. He is also a Director of Cinram International Income Fund, Cymbria Corporation, Manitoba Telecom Services Inc. and Superior Plus Inc., and non-executive Chairman of Cormark Securities Inc.
Richard H. McCoy
Member of the Audit Committee
Member of the Corporate Governance & Nominating Committee
Dick McCoy, 66, of Toronto, Canada, has served on the Board since January 2006. Mr. McCoy is a Corporate Director. He has been in the investment banking business for over 35 years. Prior to retiring in 2003, he was Vice-Chairman, Investment Banking at TD Securities Inc. Before joining TD Securities Inc. in May 1997, Mr. McCoy was Deputy Chairman of CIBC Wood Gundy Securities. Mr. McCoy also serves as a Director of ACE Aviation Holdings Inc., Uranium Participation Corporation, Gerdau Ameristeel Corp., Aberdeen Asia-Pacific Income Investment Company Limited, Jazz Air Income Fund and Pizza Pizza Royalty Income Fund.
Mary A. Mogford
Chair of the Corporate Governance & Nominating Committee
Member of the Environment, Health and Safety Committee
Member of the Human Resources & Compensation Committee
Mary Mogford, 64, of Newcastle, Canada, was appointed to the Board of the Company in 1998. She is a Corporate Director and a former Deputy Minister of Finance and Deputy Minister of Natural Resources for the Province of Ontario. Ms. Mogford is also a Director of the Potash Corporation of Saskatchewan and the SickKids Foundation Board. She was made a Fellow of the Institute of Corporate Directors in 2002 in recognition of her contribution to corporate governance in Canada. In 2004, Ms. Mogford was one of the first Directors accredited to the ICD/Rotman School of Management Directors Education Program.
Gregory P. Spivy
Member of the Corporate Governance & Nominating Committee
Member of the Human Resources & Compensation Committee
Gregory Spivy, 39, of San Francisco, U.S., was appointed to the Board in 2008. Mr. Spivy is a Partner at ValueAct Capital, a San Francisco-based investment partnership. Mr. Spivy currently serves on the boards of Adesa Holdings, Inc. and Seitel Holdings, Inc., and serves as Chairman of the Board of MSD Performance, Inc. He is also a former Director of PRA International, MSC Software Corporation and Kerr Group, Inc.
Steve M. West
Chief Executive Officer, MDS Inc.
President, MDS Nordion
Steve West was appointed Chief Executive Officer of MDS Inc. in January 2010. Mr. West, who in September 2009 was appointed Chief Operating Officer of MDS Inc., has served as President of MDS Nordion since April 2003. He joined MDS Capital Corp. (now Lumira Capital) in 2001 as a senior partner after serving as President, DiverseyLever Canada. His background includes various CEO assignments in Asia and the Pacific Rim, as well as international business-development responsibilities in the specialty chemicals field.